USPTO issues Inter Partes Reexamination Certificate of key LNA patent
5th April 2013 HOERSHOLM, Denmark and SAN DIEGO, April 5, 2013 /PRNewswire/ -- Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies,...
Japan Biosimilars - ¥200b Worth of Biologic Products Going Off Patent by 2015
12th February 2013 MUMBAI, India, February 12, 2013 /PRNewswire/ --
USPTO Grants Santaris' Request for Inter-Partes Reexamination of Patent licensed to Regulus
7th January 2013
EmergingGrowth.com Special Report on RVPlus, Inc., Oil and Gas, and Patents infringement in Pharmaceuticals
28th December 2012 MIAMI, December 28, 2012 /PRNewswire/ --
ConvaTec Prevails In Patent Case Brought By Smith & Nephew
19th December 2012
Janssen Announces Intent Not to Enforce Patents for Darunavir in Resource-Limited Settings
29th November 2012
Another Patent Granted to COPAN in the US for its Flocked Swabs Invention
12th November 2012
Harvest Technologies Corporation Files Patent Infringement Complaint against ThermoGenesis Corporation
24th October 2012
Court Focuses Patent Suit on Santaris's Safe Harbor Defense
24th September 2012
Lupin Receives FDA Approval for Generic Lexapro® Tablets
13th September 2012 MUMBAI, India and BALTIMORE, Maryland, September 13, 2012 /PRNewswire/ --
/C O R R E C T I O N -- Jazz Pharmaceuticals/
13th September 2012
Jazz Pharmaceuticals Announces Issuance of New Formulation Patent for Xyrem®
11th September 2012
Puritan Diagnostics, a division of Puritan Medical Products, Announces the Award of U.S. and Canadian Patents for HydraFlock® Swab
4th September 2012
Lupin Receives FDA Approval for Generic LYRICA(R)
5th July 2012 MUMBAI and BALTIMORE, July 5, 2012 /PRNewswire/ --
Genomic Vision Extends its Patent Portfolio With the Genomic Morse Code
3rd July 2012 PARIS, July 3, 2012 /PRNewswire/ --
ThromboGenics to Benefit From Positive Ruling Regarding Patent Income Deduction
22nd June 2012 LEUVEN, Belgium, June 22, 2012 /PRNewswire/ --
ThromboGenics and BioInvent to Regain Full Rights to TB-403
5th June 2012 LUND, Sweden and LEUVEN, Belgium, June 5, 2012 /PRNewswire/ --